| Patents for C07C 279 - Derivatives of guanidine, i.e. compounds containing the group the singly-bound nitrogen atoms not being part of nitro or nitroso groups (5,394) |
|---|
| 09/08/2006 | WO2005089734A3 Creatine salt enhanced nutritional and therapeutic efficacy and compositions containing same |
| 09/07/2006 | DE102005009990A1 Salze, Anlagerungs- und Komplexverbindungen der Guanidinoessigsäure Salts, annealing and complex compounds of guanidinoacetic |
| 09/06/2006 | CN1273446C Bearing-resisting compound and preparing method |
| 08/30/2006 | EP1445262B1 Peptide derivative, pharmaceutically acceptable salt thereof, process for producing the same, and use thereof |
| 08/29/2006 | CA2153851C Process for the preparation of radiolabeled meta-halobenzylguanidine |
| 08/24/2006 | WO2006088705A1 Terphenyl guanidines as [beta symbol] -secretase inhibitors |
| 08/24/2006 | US20060189689 Arginine mimetics as factor Xa inhibitors |
| 08/24/2006 | US20060189578 Method for the synthesis of compounds of formula I and their uses thereof |
| 08/23/2006 | EP1324981B1 Aminopyridinyl-, aminoguanidinyl- and alkoxyguanidinyl- substituted phenyl acetamides as protease inhibitors |
| 08/16/2006 | EP1689705A2 Fused ring dicationic anti-protozoan agents and their prodrugs |
| 08/16/2006 | EP1377282B1 Aryl-n-cyanoguanidines and methods related thereto |
| 08/16/2006 | EP1301467B1 9-substituted minocycline compounds |
| 08/15/2006 | CA2215476C Arginine analogues having nitric oxide synthase inhibitor activity |
| 08/10/2006 | WO2006081682A1 Creatine hydroxycitric acids salts and methods for their production and use in individuals |
| 08/09/2006 | CN1268608C Process for preparing n-dodecylguanidineacetate |
| 08/08/2006 | US7087783 Method for preparing nitrogen-containing compounds |
| 08/08/2006 | US7087769 such as the antimicrobial surfactant lauramide of L-arginine ethyl ester, by esterifying the amino acid with an alcohol, then reacting with an acyl chloride to amidate, where the pH is adjusted in the acylation step to between 6 and 6.9 |
| 08/08/2006 | US7087765 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
| 08/08/2006 | CA2188835C Novel compounds and methods for synthesis and therapy |
| 08/02/2006 | CN1810777A Compound for preventing and treating bacterial infection and its prepn and use |
| 08/01/2006 | CA2379334C Aminoguanidine bicarbonate with particular properties and method for making same |
| 07/26/2006 | EP1349578B1 Medicinal association of a biguanine (metformin) and arginine |
| 07/26/2006 | CN1266112C Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 07/20/2006 | WO2006074501A1 Peptidic compounds |
| 07/20/2006 | DE10134445B4 Bis-acylharnstoffe, deren Derivate sowie deren Verwendung Up-acylureas, their derivatives and their use |
| 07/20/2006 | CA2594411A1 Peptidic biaryl antibacterial compounds comprising one or more basic amino acids |
| 07/19/2006 | EP1680083A1 Compositions and dosage forms for ehnanced absorption of iron |
| 07/19/2006 | EP1680082A1 Compositions and dosage forms for enhanced absorption of metformin |
| 07/19/2006 | CN1805915A Indene derivatives as pharmaceutical agents |
| 07/18/2006 | US7078566 Organic acid salts for treating tumor diseases, autoimmune diseases, cardiovascular diseases, infections, and viral diseases; nonsettling by inorganic phosphates, nontoxic to tissue, inhibition of sphingomyelinase |
| 07/13/2006 | US20060154988 intracellular inhibition of bacterial polypeptide deformylase in gramnegative bacteria, |
| 07/12/2006 | EP1679305A1 9-Substituted minocycline compounds |
| 07/12/2006 | EP1678110A1 Inositol-based molecular transporters and processes for the preparation thereof |
| 07/12/2006 | EP1677759A1 Compositions and dosage forms for enhanced absorption of gabapentin and pregabalin |
| 07/12/2006 | EP1677758A1 Compositions and dosage forms for enhanced absorption of 3-amino-n-butyl-phosphinic acid |
| 07/12/2006 | EP1677757A2 Compositions and dosage forms for enhanced absorption |
| 07/12/2006 | EP1677756A2 Administration of levodopa and carbidopa |
| 07/11/2006 | US7074786 Histogranin-like peptides, processes for their preparation and uses thereof |
| 07/11/2006 | CA2309172C Aminobiguanides to disinfect contact lenses and preserve pharmaceutical compositions |
| 07/06/2006 | US20060148760 Method for the sysnthesis of compounds of formula I and their uses thereof |
| 07/06/2006 | DE102004060076A1 Verfahren zur Herstellung von Onium-Salzen mit Alkyl- oder Arylsulfonat-Anionen oder Alkyl- oder Arylcarboxylat-Anionen mit geringem Halogenid-Gehalt A process for the preparation of onium salts with alkyl- or arylsulfonate anions or alkyl- or arylcarboxylate anions having a low halide content |
| 07/05/2006 | EP1675822A2 Amide or thioamide derivatives and their use in the treatment of pain |
| 07/05/2006 | EP1675821A1 Phenetanolamine derivatives |
| 07/05/2006 | EP1675818A1 Method for synthesis of acrylamide derivatives |
| 07/05/2006 | CN1262538C Method for preparation of guanifine derivatives |
| 06/29/2006 | WO2006066894A1 Compounds for treating metabolic syndrome |
| 06/29/2006 | WO2005072246A3 Facially amphiphilic polyaryl and polyarylalkynyl polymers and oligomers and uses thereof |
| 06/29/2006 | US20060142594 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
| 06/29/2006 | DE102004060074A1 Verfahren zur Herstellung von Onium Alkylsulfaten mit geringem Halogenid-Gehalt A process for the preparation of onium alkylsulfates with low halide content |
| 06/29/2006 | DE102004060073A1 Producing onium tetrafluoroborates useful as ionic liquids comprises reacting an onium halide with a trialkyloxonium, trialkylsulfonium or triphenylcarbonium tetrafluoroborate |
| 06/28/2006 | EP1154767B9 Substituted stilbene compounds with vascular damaging activity |
| 06/27/2006 | US7067698 Preparation of preferential oligomers for use as therapeutic tools; obtain oligomer, incubate with amines, expose to guanidinylation reagent, recover oligomer |
| 06/27/2006 | US7067697 introducing a biologically active agent into a cell of a plant or animal comprising: contacting said cell with lipid vesicles comprising amino acid amide lipids in vivo or in vitro; gene therapy |
| 06/27/2006 | US7067554 Method for the synthesis of compounds of formula I and their uses thereof |
| 06/27/2006 | US7067476 Peptide derivative containing hydroxy or carbonyl groups and a residue of arganine and lysine side chain in which guanidino and amino groups are protected; used for periodontal disease |
| 06/22/2006 | WO2006063656A1 Method for producing onium salts comprising alkyl anions or aryl sulfonate anions or alkyl anions or aryl carboxylate anions having a low halide content |
| 06/22/2006 | WO2006063654A1 Method for producing onium alkyl sulfates with a low halogenide content |
| 06/22/2006 | WO2006063653A1 Method for the production of onium salts with tetrafluoroborate anion having a reduced halide content |
| 06/22/2006 | WO2006051314A3 Guanidine derivatives as inhibitors of ddah |
| 06/22/2006 | US20060134130 Oral drug delivery compositions and methods |
| 06/22/2006 | CA2590780A1 Process for the preparation of onium salts with a tetrafluoroborate anion having a reduced halide content |
| 06/21/2006 | EP0923600B1 Novel cationic amphiphilic lipids for liposomal gene transfer |
| 06/15/2006 | US20060127309 Imaging agents |
| 06/07/2006 | CN1784381A Method for crystallizing guanidinium salts |
| 06/07/2006 | CN1258520C Phosphoric-amino acids salts and additive composition containing the same and use in ruminant feed |
| 06/06/2006 | US7056902 4-dedimethylamino tetracycline compounds |
| 05/31/2006 | EP1296931B1 Polyamine analogues as cytotoxic agents |
| 05/25/2006 | US20060111553 Novel thrombin inhibitors, the preparation and use thereof |
| 05/24/2006 | EP1261581B1 Method for producing 1-methyl-3-nitroguanidine |
| 05/24/2006 | CN1777577A Antibacterial agents |
| 05/23/2006 | US7049460 Aromatic guanidine compound; antitumor agents; anticancer agents |
| 05/23/2006 | US7049344 arylguanidine derivatives, for example N-[4-(2,3-bis-Bocguanidino)benzyl]2-(benzyl-oxycarbonyl)-2-phenylaceataride, N-(4-guanidinobenzyl) 2-(benzyloxycarbonyl)-2-phenylacetamide hydrochloride; antimetastasis agents |
| 05/18/2006 | WO2006051314A2 Guanidine derivatives as inhibitors of ddah |
| 05/18/2006 | CA2587444A1 Guanidine derivatives as inhibitors of ddah |
| 05/16/2006 | CA2197628C Substituted thiophenylalkenylcarboxylic acid guanidides, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 05/11/2006 | WO2005123646A3 Fluoroorganic compounds and anti-fouling treatments |
| 05/11/2006 | US20060100225 Heteroaryl guanidines; inhibitors of viral replication |
| 05/09/2006 | CA2257328C Thiazole derivatives |
| 05/09/2006 | CA2125105C Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic and medicament containing them |
| 05/04/2006 | US20060094902 Amino acid analogues |
| 05/04/2006 | US20060094782 Compositions and dosage forms for enhanced absorption |
| 05/03/2006 | EP1528923B1 N-((3-oxo-2,3-dihydro-1h-isoindol-1-yl)acetyl)guanidine derivatives as nhe1-inhibitors for the treatment of infarction and angina pectoris |
| 05/02/2006 | USRE39088 Amide compounds and use of the same |
| 05/02/2006 | US7038074 Arginine mimetics as factor Xa inhibitors |
| 05/02/2006 | CA2206005C Aniline derivatives possessing an inhibitory effect of nitric oxide synthase |
| 04/27/2006 | WO2006044707A1 Chemical compounds |
| 04/27/2006 | WO2005072121A3 Carrier ampholytes of high ph range |
| 04/27/2006 | US20060089336 4-Dedimethylamino tetracycline compounds |
| 04/25/2006 | US7034057 Controlling tumor necrosis factor; antiinflamamtory agents, autoimmune disease |
| 04/19/2006 | EP1646371A2 Antiviral compounds and methods |
| 04/19/2006 | EP1481002B1 Histogranin-like peptides and non-peptides, processes for their preparation and uses thereof |
| 04/19/2006 | CN1760177A Improved technique for producing tetramethyl guanidine |
| 04/11/2006 | US7026297 Neuroprotective agents |
| 04/05/2006 | EP1642888A1 compounds for modulating the rage receptor |
| 04/05/2006 | EP0933993B1 Substituted cyclopentane compounds useful as neuraminidase inhibitors |
| 04/05/2006 | CN1249026C N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them |
| 04/04/2006 | US7022214 guanidine and carboxyalkyl substituted polyalkylene polyamines with high isoelectric points; isoelectric focusing of proteins |
| 03/30/2006 | US20060069100 Variously substituted derivatives of guanidine, and their use as medicines with anti-diabetes and/or anti-obesity activity |
| 03/30/2006 | US20060067880 Labeled creatine ethyl ester hydrochloride |
| 03/30/2006 | DE102004043938A1 Pentafluorosulfanylphenyl-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament Pentafluorosulfanylphenyl-substituted benzoylguanidines, processes for their preparation, their use as a medicament or diagnostic, and they drug-containing |